TRACON and Nycomed, for the funding or
conduct of further development and commercialization activities relating to
our product candidates. You are urged to consider statements that include
the words "ongoing", "may", "will", "would", "could", "should", "believes",
"estimates", "projects", "potential", "expects", "suggests", "plans",
"anticipates", "intends", "continues", "forecast", "designed", "goal", or
the negative of those words or other comparable words to be uncertain and
forward-looking. These factors and others are more fully discussed in our
periodic reports and other filings with the SEC.
Any forward-looking statements are made pursuant to Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, and, as such, speak only as of the date
made. Micromet, Inc. undertakes no obligation to publicly update any
forward-looking statements, whether as a result of new information, future
events or otherwise.
'/>"/>SOURCE Micromet, Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference2.
KGI Elects Three New Members to Board of Trustees3.
The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors4.
Genaera Elects New Board Member and Announces Executive Appointments5.
MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions6.
Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors7.
Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software8.
Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets9.
Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board10.
DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board11.
Nektar Therapeutics Appoints Lutz Lingnau as New Board Member